000 01097 a2200313 4500
005 20250513122047.0
264 0 _c19970912
008 199709s 0 0 eng d
022 _a0966-842X
024 7 _a10.1016/S0966-842X(97)01051-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNicas, T I
245 0 0 _aBeyond vancomycin: new therapies to meet the challenge of glycopeptide resistance.
_h[electronic resource]
260 _bTrends in microbiology
_cJun 1997
300 _a240-9 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnti-Bacterial Agents
_xchemical synthesis
650 0 4 _aDrug Resistance, Microbial
650 0 4 _aGram-Positive Bacterial Infections
_xtherapy
650 0 4 _aHumans
650 0 4 _aImmunization
650 0 4 _aImmunotherapy
650 0 4 _aMolecular Structure
650 0 4 _aVancomycin
_xchemistry
700 1 _aZeckel, M L
700 1 _aBraun, D K
773 0 _tTrends in microbiology
_gvol. 5
_gno. 6
_gp. 240-9
856 4 0 _uhttps://doi.org/10.1016/S0966-842X(97)01051-2
_zAvailable from publisher's website
999 _c9192057
_d9192057